NewsScientists use nanoparticle-delivered gene therapy to
inhibit blinding eye disease in rodents

7th July 2020by admin0
https://nfusion-tech.com/wp-content/uploads/2020/07/scientists-use-nanoparticle-delivered-gene-therapy-toinhibit-blinding-eye-disease-in-rodents_5f0af01590501.jpeg

In experiments in rats and mice, two Johns Hopkins
scientists—an engineer and an ophthalmologist—report the successful
use of nanoparticles to deliver gene therapy for blinding eye
disease. A uniquely engineered large molecule allows researchers to
compact large bundles of therapeutic DNA to be delivered into the
cells of the eye.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2020 New Fusion All Rights Reserved

      Designed by FallingBrick


      Warning: Creating default object from empty value in /homepages/9/d775151175/htdocs/nfusion-tech.com/wp-content/plugins/applauz/framework_bt_plugin/.framework_bt_plugin.php on line 1640